Genmab Publishes 2024 Annual Report

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. QGEN
10. SPY

Go back to Genmab Publishes 2024 Annual Report

Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)

February 13, 2025 7:17 AM EST

Truist Securities analyst Asthika Goonewardene reiterated a Buy rating and $50.00 price target on Genmab A/S (NASDAQ: GMAB).

The analyst comments "We believe investors are anxious to own GMAB ahead of J&J's (JNJ, Not Rated) decision to opt-in on GEN3014, and... More